AFT PHARMACEUTICALS

AFT PHARMACEUTICALS

AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals_logo
Social Links:

Industry:
Organization

Founded:
9/4/1997

Address:
129 Hurstmere Road, Auckland, New Zealand Zipcode 0622

Country:
New Zealand

Phone:
64 9 488 0232

Market Cap:
449.71M
Total Revenue:
105.6M
Total Assets:
87.05M
Total Cash:
6.12M

Subsidiaries: Dermatology Specialities, L.P. · DSGP Limited


Key Executives
Name Title Pay Year Born
Dr. Hartley Atkinson Founder, CEO, MD & Exec. Director 592,353$ N/A
Ms. Marree Atkinson Chief of Staff & Exec. Director 130,489$ N/A
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ CFO & Company Sec. N/A N/A
Mr. Murray Keith Group Marketing Mang. N/A N/A
Ms. Ioana Stanescu Head of Drug Devel. N/A N/A
Mr. Calvin Mackenzie Gen. Mang. of AFT Australia N/A N/A
Mr. Scott Crawford Gen. Mang. of Promoted Products Australasia & South East Asia N/A N/A
Ms. Louise Clayton Director of International Bus. N/A N/A



Financial & Stock
Exchange NZSE. Currency in NZD. Market state POSTPOST
According to AFT Pharmaceuticals's financial reports the company's revenue in 2020 were 105.6M an decrease( +23.53%) over the years 2019 revenue that were of 85.13M. In 2020 the company's total earnings were 12.69M while total earnings in 2019 were -2.43M(-700%).
Company's stock symbol is AFT.NZ. Lastest price : 4.3000. Total volume :45.84k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.aftpharm.com

  • Host name: ec2-52-42-167-42.us-west-2.compute.amazonaws.com
  • IP address: 52.42.167.42
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...
Loading ...


More informations about "AFT Pharmaceuticals" on Search Engine

Home | AFT Pharmaceuticals

Aftpharm.com The vision of AFT orphan is to be the leading company in Asia, Australia and New Zealand providing access to orphan medicines for patients suffering from rare diseases.

Home | AFT Pharmaceuticals

Aftpharm.com View our range of Prescription and Non-Prescription products.

Home | AFT Pharmaceuticals

Aftpharm.com NEW ZEALAND. Level 1, 129 Hurstmere Road, Takapuna, Auckland, 0622. PO Box …

Home | AFT Pharmaceuticals

Aftpharm.com AFT Pharmaceuticals was formed with a big dream in mind. In Australasia, our product …

Home | AFT Pharmaceuticals

Aftpharm.com Before establishing AFT Pharmaceuticals, Hartley had 8 years in multinational …

Home | AFT Pharmaceuticals

Aftpharm.com AFT Pharmaceuticals is a fast growing company listed on both the NZX and ASX, …

Home | AFT Pharmaceuticals

Aftpharm.com January 13, 2021 AFT confirms demonstration of 24-hour efficacy for Crystawash Extend …

Home | AFT Pharmaceuticals

Aftpharm.com "Research and development (R&D) sits at the heart of AFT Pharmaceuticals" Hartley …

Home | AFT Pharmaceuticals

Aftpharm.com He joined AFT Pharmaceuticals in 2006 as Regulatory Affairs Manager. Vladimir has …

Home | AFT Pharmaceuticals

Aftpharm.com AFT Pharmaceuticals is granted Early Point Project (EPP) status for an orphan drug …

AFT AFT Pharmaceuticals Ltd Ordinary Shares - NZX, New

Nzx.com AFT Pharmaceuticals Ltd Ordinary Shares Issued By: AFT Pharmaceuticals Limited: ISIN: NZAFTE0001S4: Type: Ordinary Shares: Activity. Trading status: Trading: Trades: 102: Value: ... AFT Price History Load Interactive Charts View AFT Pharmaceuticals Limited Announcements . Markets ...

AFT Pharmaceuticals (NZSE:AFT) - Share price, News

Simplywall.st AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-p... Company Analysis and Financial Data Status Unless specified all financial data is based on a yearly period but updated quarterly.

AFT PHARMACEUTICALS Share Price - AFT Share Price

Stockopedia.com 31 rows · The AFT Pharmaceuticals PE ratio based on its reported earnings over the past 12 months …

AFT:NZX Stock Quote - AFT Pharmaceuticals Ltd - Bloomberg

Bloomberg.com AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products. The Company offers medicines for allergy, cough, cold, and flu, eye care, pain management, and laxatives. AFT...

AFT Pharmaceuticals makes $72 million deal | Stuff.co.nz

Stuff.co.nz Jun 10, 2020 · The founders of Kiwi drug company AFT Pharmaceuticals are selling a small portion of their stake for $3.5 million to increase its accessibility on the New Zealand and Australian sharemarkets.

AFT Pharmaceuticals - A strong start to FY20 | Edison

Edisongroup.com Nov 25, 2019 · AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC products through its own salesforce in New Zealand, Australia and South-East Asia. The company recently reported its H120 results. Operating revenue grew by a strong 22.1% year-on-year as there was growth across all regional segments, …

AFT Pharmaceuticals - Overview, News & Competitors

Zoominfo.com AFT Pharmaceuticals. AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products ac...

AFT Pharmaceuticals | LinkedIn

Linkedin.com AFT Pharmaceuticals was formed with a big dream in mind. In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala...

AFT Pharmaceuticals | Share Price, Company News & Analysis

Edisongroup.com Mar 31, 2021 · AFT Pharmaceuticals is a specialty pharmaceutical company that operates primarily in Australasia but has product distribution agreements across the globe. The company’s product portfolio includes prescription and over-the-counter drugs to treat a …

Timber Pharmaceuticals’ Development Partner, AFT

Finance.yahoo.com - Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe - Basking Ridge, N.J., March 17, 2021 (GLOBE NEWSWIRE ...

AFP Stock Price | AFT Pharmaceuticals Ltd. Stock Quote

Marketwatch.com AFT Pharmaceuticals Ltd. AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic ...

AFT Pharmaceuticals : Crystawash Extend distribution in

Marketscreener.com 1 day ago · About AFT Pharmaceuticals AFT is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.

AFP | AFT Pharmaceuticals Ltd. Stock Price & News - WSJ

Wsj.com View the latest AFT Pharmaceuticals Ltd. (AFP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

AFT Pharmaceuticals Ltd Ordinar (AFT.NZ) Stock Price, News

Finance.yahoo.com The big shareholder groups in AFT Pharmaceuticals Limited (NZSE:AFT) have power over the company.

Timber Pharmaceuticals’ Development Partner, AFT

Markets.businessinsider.com Mar 17, 2021 · Timber Pharmaceuticals’ Development Partner, AFT Pharmaceuticals, Enters into Licensing Agreement for Pascomer® (TMB-002) in Europe PRESS RELEASE GlobeNewswire Mar. …

Hyloris’ Partner AFT Pharmaceuticals Signs Licensing

Globenewswire.com Mar 05, 2021 · Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets Footprint across Europe now extended to a total of 20 EU member states ...

AFT Pharmaceuticals : licenses Pascomer for EuropeOpens in

Marketscreener.com AFT is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. Historically, AFT's home markets have been Australia, New Zealand and South-East Asia.

Aft Pharmaceuticals (au) Pty Ltd - ABN, ACN, Business

Aubiz.net Aft Pharmaceuticals (au) Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2003-08-08 and was issued with the 105636413 ACN. Its Australian Business Number is 29105636413. Since 2016-08-12, the …

AFT Pharmaceuticals - Home | Facebook

Facebook.com AFT Pharmaceuticals, Auckland, New Zealand. 783 likes · 50 talking about this · 26 were here. We develop, license, and sell pharmaceutical products in Australasia & around the world. Our commitment...

AFT Pharmaceuticals - Crunchbase Company Profile & Funding

Crunchbase.com AFT is a Pharmaceutical sales and development company. AFT Pharmaceuticals develops, licenses, and sells a range of medical products globally.

AFP share price and company information for ASX:AFP

Www2.asx.com.au View today’s AFP share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer …

AFT Pharmaceuticals | Pharmaceutical.Report

Pharmaceutical.report AFT Pharmaceuticals was formed with a big dream in mind. In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 109 countries. Plus our Orphan Drugs Foundation provides access to lower ...

AFT Stock Price | AFT Pharmaceuticals Ltd. Stock Quote

Marketwatch.com AFT Pharmaceuticals Ltd. AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic ...

AFT Pharmaceuticals : AFP opening European office, signs

Marketscreener.com About AFT Pharmaceuticals AFT is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.

AFT Pharmaceuticals - Solid FY20 results | Edison

Edisongroup.com May 21, 2020 · AFT Pharmaceuticals is a specialty pharmaceutical company that operates primarily in Australasia but has product distribution agreements across the globe. The company’s product portfolio includes prescription and over-the-counter drugs to treat a …

Timber Pharmaceuticals’ Development Partner, AFT

Nasdaq.com Mar 17, 2021 · - Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe- …

Hyloris' Partner AFT Pharmaceuticals Signs Licensing

Benzinga.com Mar 05, 2021 · Hyloris' Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets Footprint across Europe now extended to a total of 20 EU member states ...

AFT PHARMACEUTICALS LIMITED : AFT Stock Price

Marketscreener.com AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others.

CRG | Portfolio | Aft Pharmaceuticals | Further Us

Crglp.com Specialty Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised a follow-on equity capital raise with CRG (formerly Capital Royalty L.P.), Atkinson family, AFT board members, and a group of specialist pharma investors from the United States.

Annual Report 2018 - AFT Pharmaceuticals

Investors.aftpharm.com 4 AFT PHARMACEUTICALS LIMITED EY HIGHLIGHTS 5 Annual Report 2018 Delivering ountries ed. We remain highly committed to commercialising our Key Innovative Products. David Flacks CHAIRMAN Our key efforts are now shifting towards product launches in the out-licensed territories.

AFT Pharmaceuticals Ltd Ordinar (AFT.NZ) Interactive Stock

Finance.yahoo.com Interactive Chart for AFT Pharmaceuticals Ltd Ordinar (AFT.NZ), analyze all the data with a huge range of indicators.

AFT PHARMACEUTICALS LIMITED : Shareholders Board Members

Marketscreener.com AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others.

Aft Pharmaceuticals Ltd., 2 Freight Pl, Mangere, Auckland

Panjiva.com Aft Pharmaceuticals Ltd. at 2 Freight Pl, Mangere, Auckland 2022, New Zealand. Find their customers, contact information, and details on 49 shipments.

AFT | AFT Pharmaceuticals Ltd. Stock Price & News - WSJ

Wsj.com View the latest AFT Pharmaceuticals Ltd. (AFT) stock price, news, historical charts, analyst ratings and financial information from WSJ.